Previous and current results of the treatment of ADD/ADHD with Neurofeedback are promising for those individuals demonstrating certain Quantitative EEG and behavioral characteristics. Practitioners utilizing this treatment modality recognize that the disorders of ADD or ADHD are complex and have a wide range of symptoms, etiologies, and therapeutic interventions. Neurofeedback offers patients a psychophysiological treatment which when combined with other traditional therapies produces significant improvement for many patients. More research, currently being conducted, is needed and extend these results. To date, this treatment has been successfully applied for over three thousand children, adolescents, and adults treated by approximately four hundred fifty Health Care Organizations. Neurofeedback is neither a panacea nor a cure but a Powerful adjunctive technique.

WHO IS A CANDIDATE FOR NEUROFEEDBACK THERAPY?

Anyone with a primary diagnosis of ADD or ADHD, between the ages of 7 and 45, with low average, average, or above
average intelligence. Neurofeedback treatment should not be offered with co-morbidity of:

Mental Retardation Childhood Psychosis
Severe depressive or bipolar illness
Significant seizure disorder where medications interfere with learning (i.e., sedating medications)
Hyperkinesis, where multiple medications or high dosages with monotherapy have been ineffective
Learning disabilities without ADD or ADHD as a primary problem
Dysfunctional families who refuse to participate in indicated therapy

WHAT SYMPTOMS CAN BE IMPROVED WITH NEUROFEEDBACK?

Attention, focus and concentration
Task completion and organizational skills
Impulsiveness
Mild hyperactivity

WHAT ARE THE RESULTS OF TREATMENT?

Improved behavior and learning
Improvement in school grades
Increased self-esteem
Better job performance
Greater realization of innate potential
Higher intelligence test scores
Improved scores on Parent-Teacher rating scales

HOW EFFECTIVE IS THIS TREATMENT APPROACH?

When the above criteria are used to select candidates for therapy and treatment, the majority of patients completing treatment
show marked improvement. The improvement is measured and validated by improvement in the results listed above and are
measured by independent observers and testing, reports by teachers, parents, and other involved health care professionals.

Author's Bio: 

Dr. Philip Brotman
Biofeedback Instrument Corporation
255 W. 98th Street
New York, N.Y. 10025
Tel. (212) 222-5665 (5667 Fax)
Email: ac@inx.net